{"id":161653,"date":"2026-09-08T00:59:17","date_gmt":"2026-09-08T00:59:17","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/161653\/"},"modified":"2026-09-08T00:59:17","modified_gmt":"2026-09-08T00:59:17","slug":"pharma-wastewater-could-become-production-water-cutting-use-50","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/161653\/","title":{"rendered":"Pharma wastewater could become production water, cutting use 50%"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Novo Nordisk is testing whether wastewater from pharmaceutical production can be cleaned well enough to be used again in the manufacturing process, potentially cutting the company\u2019s water consumption by half.<\/p>\n<p class=\"wp-block-paragraph\">The project, being carried out with researchers at the Technical University of Denmark (DTU), targets one of the more difficult forms of industrial water recycling. Pharmaceutical manufacturing requires highly purified water, particularly when the water is used to produce injectable medicines.<\/p>\n<p class=\"wp-block-paragraph\">The need is becoming more pressing. An analysis by the Danish Academy of Technical Sciences found that Denmark\u2019s overall industrial water consumption was almost unchanged between 2012 and 2022. Pharmaceutical manufacturing was an exception, with its water consumption increasing 35.8% during the period.<\/p>\n<p class=\"wp-block-paragraph\">Novo Nordisk currently reuses some process water in cooling towers, where the water helps remove excess heat before eventually evaporating. The company now wants to determine whether wastewater generated directly by pharmaceutical production can instead be treated and returned to the manufacturing process.<\/p>\n<p>Reverse osmosis targets cleaner reuse<\/p>\n<p class=\"wp-block-paragraph\">\u201cIf we can recycle the wastewater streams that come from the processes in the pharmaceutical production itself, we estimate that we can reduce our water consumption by 50 per cent,\u201d said Andreas Herfelt, Environmental Lead at Novo Nordisk.<\/p>\n<p class=\"wp-block-paragraph\">To test that possibility, DTU researcher Ravi Kumar Chhetri installed membrane-based water purification technology at Novo Nordisk\u2019s Hiller\u00f8d facility in December 2025. The system uses reverse osmosis, a process that pushes water through a semipermeable membrane to separate it from dissolved substances.<\/p>\n<p class=\"wp-block-paragraph\">The technology alone, however, is not enough to determine whether the treated water can return to pharmaceutical production. Researchers need to establish what remains in the purified water and whether those substances could affect drug quality or patient safety.<\/p>\n<p class=\"wp-block-paragraph\">Chhetri and his colleagues are therefore continuously analysing water samples collected after the membrane treatment. The results will feed into risk assessments examining whether any remaining substances present a meaningful concern.<\/p>\n<p class=\"wp-block-paragraph\">\u201cThis is because the water used in the production of pharmaceuticals \u2013 and especially those that are to be injected \u2013 is subject to the strictest quality requirements. This is to prevent unwanted substances from ending up in the patients who need the medicine,\u201d said Herfelt.<\/p>\n<p>Purified water faces strict tests<\/p>\n<p class=\"wp-block-paragraph\">The project is designed to provide Novo Nordisk with the technical evidence needed to demonstrate that recycled process water meets the necessary standards. Professor Anders Baun is also involved in preparing the risk analyses.<\/p>\n<p class=\"wp-block-paragraph\">\u201cIn the risk analyses, we assess whether there are substances remaining in the purified water and whether they pose a high or low risk. If the risk is at the high end, we look at how to address it,\u201d said Chhetri.<\/p>\n<p class=\"wp-block-paragraph\">That makes the project different from conventional industrial water-saving efforts. Instead of simply reducing the amount of <a href=\"https:\/\/interestingengineering.com\/innovation\/youtuber-tests-50000-volt-system\" target=\"_blank\" rel=\"dofollow noopener\">water<\/a> used in a process, researchers are investigating whether the same water can be cleaned and cycled back into production.<\/p>\n<p class=\"wp-block-paragraph\">\u201cRecycling water in a production company has great potential for water savings compared to other water-saving measures such as optimizing processes with high water consumption,\u201d said Chhetri.<\/p>\n<p class=\"wp-block-paragraph\">For Novo Nordisk, proving that the treated water is safe enough for <a href=\"https:\/\/interestingengineering.com\/science\/engineered-bacteria-convert-plastic-parkinsons-drug\" target=\"_blank\" rel=\"dofollow noopener\">pharmaceutical<\/a> production could also strengthen water security, particularly in areas where local water resources are under pressure.<\/p>\n<p class=\"wp-block-paragraph\">\u201cIt is with DTU\u2019s help that we can obtain the necessary data for the Danish Medicines Agency as documentation that recycling the water will not pose any risk to either the quality of our products or patient safety,\u201d said Herfelt.<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk is testing whether wastewater from pharmaceutical production can be cleaned well enough to be used again&hellip;\n","protected":false},"author":2,"featured_media":161654,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[75740,75741,272,52667,75742,27613,75743,47916],"class_list":["post-161653","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-dtu","tag-membrane-technology","tag-novo-nordisk","tag-pharmaceutical-manufacturing","tag-reverse-osmosis","tag-wastewater-treatment","tag-water-conservation","tag-water-recycling"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117232714821748792","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/161653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=161653"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/161653\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/161654"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=161653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=161653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=161653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}